Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design

BACKGROUND: Screening for coronary artery disease (CAD) remains broadly performed in patients with type 2 diabetes (T2DM), although the lack of evidence. We conduct a real-world evidence (RWE) study to assess the risk of major clinical outcomes and economic impact of routine CAD screening in T2DM in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammedi, Kamel, Préaubert, Nathalie, Cariou, Tanguy, Rigalleau, Vincent, Foussard, Ninon, Piazza, Laurent, Bairras-Martin, Céline, Couffinhal, Thierry, Bezin, Julien, Benard, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955624/
https://www.ncbi.nlm.nih.gov/pubmed/33714278
http://dx.doi.org/10.1186/s12933-021-01253-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955624/
https://www.ncbi.nlm.nih.gov/pubmed/33714278
http://dx.doi.org/10.1186/s12933-021-01253-2

Ejemplares similares